Examine the technical details of our research study to test against microbial attack, including the efficacy of GLS™ TPES with antimicrobial additives

Custom GLS™ Thermoplastic Elastomer replaced thermoset rubber for tourniquet band

Examine the technical details of our research study to test against microbial attack, including the efficacy of GLS™ TPES with antimicrobial additives

Bergamid™ polymer formulations and GLS™ TPEs replace metal and provide comfort and usability for Swiss soldiers pocket knife

Custom GLS™ Thermoplastic Elastomer replaced thermoset rubber for tourniquet band

Examine the technical details of our research study to test against microbial attack, including the efficacy of GLS™ TPES with antimicrobial additives

Examine the technical details of our research study to test against microbial attack, including the efficacy of GLS™ TPES with antimicrobial additives

GLS Thermoplastic Elastomer based impact modifier used to increase stiffness, lower weight and reduce cost for a storage tote

& Canada 50% Latin America 2021 SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS 19% Building and END MARKET REVENUE (1) Total company sales and adjusted EBITDA of $4,819M and $581M, respectively, include intercompany sales eliminations and corporate costs $2,402M $409M $919M $164M $1,631M $94M Sales EBITDA Distribution Specialty Engineered Materials Color Additives and Inks $581M$4,819M (1) 24 34% Building & 1% Telecommunications C O L O R , A D D I T I V E S & I N K S 2021 REVENUE | $2 .4 BILL ION 32% 40% Latin America END MARKET REGION 25 S P E C I A LT Y E N G I N E E R E D M AT E R I A L S 27% Building & 2021 REVENUE | $919 MILLION END MARKET 55% REGION 26 D I S T R I BU T I O N 26% Building and 80% 3% Latin America END MARKET REGION K E Y S U P P L I ER S 2021 REVENUE | $1 .6 B ILL ION 27 TOTA L C O M PA N Y R E G I O N A L S A L E S BY END MARKET 30% 26%Healthcare 14% Building & 2% Energy (16% of sales) 32% Building & (25% of sales) 28 19% Building & US & Canada (50% of sales) 38% 33% Building & LATAM (9% of sales) Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

& Canada 40% 37% 18% 2022 PRO FORMA SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS Building and END MARKET REVENUE $2,355M $402M $1,300M $272M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $592M$3,653M (1) 9% 30 (1) Total company sales and adjusted EBITDA of $3,653M and $592M, respectively, include intercompany sales eliminations and corporate costs 2022 REVENUE | $2 .4 B ILL ION 34% 38% END MARKET REGION 31 34% 21% Building & 1% Energy 2% COLOR, ADDITIVES & INKS 2022 PRO FORMA REVENUE | $1 .3 B ILL ION 52% 35% 32 19% 8%Industrial 16% 9% Defense Building & END MARKET REGION SPECIALTY ENGINEERED MATERIALS 32% 27% 14% Building & 3% 1% Defense 1% (18% of sales) 9% 2022 PROFORMA AVIENT REGIONAL SALES 27% 14% 17% Building & (37% of sales)Transportation 12% Building & US & Canada (40% of sales) 7% 56% 23% 7% Building & 1% LATAM (5% of sales) 3% 33 BY END MARKET Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.